Latest News for: vertex
Edit
Statement of Changes in Beneficial Ownership (Form 4) (Vertex Pharmaceuticals Incorporated)
Public Technologies 12 Feb 2026
VERTEX PHARMACEUTICALS INC / MA [VRTX] 5 ... C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE 3 ... C/O VERTEX PHARMACEUTICALS INCORPORATED ... Vertex Pharmaceuticals Incorporated published this ...
Edit
Statement of Changes in Beneficial Ownership (Form 4) (Vertex Inc)
Public Technologies 12 Feb 2026
Edit
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue
The Call 12 Feb 2026
Biotech company Vertex Pharmaceuticals (NASDAQ ... Is now the time to buy Vertex Pharmaceuticals? Find out by accessing our full research report, it’s free. Vertex Pharmaceuticals (VRTX) Q4 CY2025 Highlights..
Edit
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results (Form 8-K) (Vertex Pharmaceuticals Incorporated)
Public Technologies 12 Feb 2026
) Vertex Reports Fourth Quarter and Full Year 2025 Financial Results ... BOSTON -- Vertex Pharmaceuticals Incorporated (Nasdaq ... operating activities, partially offset by repurchases of Vertex's common stock pursuant to its share repurchase programs.
Edit
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results (Vertex Pharmaceuticals Incorporated)
Public Technologies 12 Feb 2026
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results ... 12, 2026-- Vertex Pharmaceuticals Incorporated (Nasdaq ... Vertex today provided full year 2026 financial guidance ... Vertex's financial guidance is summarized below.
Edit
Q4 2025 Presentation (6759ed5a 3de5 4ea9 81b2 ba99abfb333f) (Vertex Pharmaceuticals Incorporated)
Public Technologies 12 Feb 2026
©2026 Vertex Pharmaceuticals Incorporated. ©2026 Vertex Pharmaceuticals Incorporated ... Vertex disclaims any obligation to update the information contained in this presentation as new information becomes available ... Vertex capabilities.
Edit
Notice of Proposed Sale of Securities (Form 144) (Vertex Pharmaceuticals Incorporated)
Public Technologies 11 Feb 2026
Vertex Pharmaceuticals Incorporated published this content on February 11, 2026, and ...
Edit
Vertex Announces Fourth Quarter and Full Year 2025 Financial Results
Nasdaq Globe Newswire 11 Feb 2026
Edit
Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect
The Call 11 Feb 2026
Biotech company Vertex Pharmaceuticals (NASDAQ ... Vertex Pharmaceuticals met analysts’ revenue expectations last quarter, reporting revenues of $3.08 billion, up 11% year on year ... Is Vertex ...
Edit
Vertex Announces Fourth Quarter and Full Year 2025 Financial Results (Form 8-K) (Vertex Inc)
Public Technologies 11 Feb 2026
Edit
Subba Rao joins Vertex Group as co-founder and Chief Growth Officer
The Times of India 10 Feb 2026
.
Edit
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
The Buffalo News 03 Feb 2026
... agreement with Vertex Pharmaceuticals Incorporated (Nasdaq.
Edit
Vertex Report: U.S. Sees Record-Level Growth in Sales Tax Rates and Rules Changes in 2025 ...
Nasdaq Globe Newswire 03 Feb 2026
2025 data reveals a 10-year high in new taxes enacted, and the first ...
- 1
- 2
- Next page »
